Failure to Prevent Severe Graft-Versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide in Chronic Granulomatous Disease

Alopecia Areata

Histological and clinical cross-sectional study of chronic hair loss in patients with cutaneous chronic graft-versus-host disease

J Am Acad Dermatol.

Marks DH, Naftulin JS, Penzi LR, Manatis-Lornell A, Yasuda MR, Chapman CM, Rao SR, Saavedra A, Senna MM

doi: 10.1016/j.jaad.2019.03.031.

COMMENTED

T Cells

Dipeptidyl Peptidase 4 Inhibition for Prophylaxis of Acute Graft-versus-Host Disease

★ 1 Recommended and commented by Prof. emer. Dr Ulrich Keller, Faculty Member

N Engl J Med

Farag SS, Abu Zaid M, Schwartz JE, Thakrar TC, Blakley AJ, Abonour R, Robertson MJ, Broxmeyer HE, Zhang S

doi: 10.1056/NEJMoa2027372

T Cells

Dipeptidyl Peptidase 4 Inhibition for Prophylaxis of Acute Graft-versus-Host Disease

★ 1 Recommended and commented by Prof. emer. Dr Ulrich Keller, Faculty Member

N Engl J Med

Farag SS, Abu Zaid M, Schwartz JE, Thakrar TC, Blakley AJ, Abonour R, Robertson MJ, Broxmeyer HE, Zhang S

doi: 10.1056/NEJMoa2027372

MicroRNA-155 Modulates Acute Graft-versus-Host Disease by Impacting T Cell Expansion, Migration, and Effector Function

J Immunol.

Zitzer NC, Snyder K, Meng X, Taylor P, Efebera YA, Devine SM, Blazar BR, Garzon R, Ranganathan P

doi: 10.4049/jimmunol.1701465.

Immunodeficiency

Inflammatory Bowel Disease in Chronic Granulomatous Disease: an emerging problem over a twenty years' experience

Pediatr Allergy Immunol.

Angelino G, De Angelis P, Faraci S, Rea F, Romeo EF, Torroni F, Tambucci R, Claps A, Francalanci P, Chiriaco M, Di Matteo G, Cancrini C, Palma P, D'Argenio P, Dall'Oglio L, Rossi P, Finocchi A

doi: 10.1111/pai.12814.

Immunodeficiency

Outcome of Non-hematological Autoimmunity After Hematopoietic Cell Transplantation in Children with Primary Immunodeficiency

J Clin Immunol

Lum SH, Elfeky R, Achini FR, Margarit-Soler A, Cinicola B, Perez-Heras I, Nademi Z, Flood T, Cheetham T, Worth A, Qasim W, Amin R, Rao K, Chiesa R, Bredius RGM, Amrolia P, Abinun M, Hambleton S, Veys P, Gennery AR, Lankester A, Slatter M

doi: 10.1007/s10875-020-00895-3

Hematopoietic stem cell therapy for autoimmune diseases - Clinical experience and mechanisms

J Autoimmun.

Alexander T, Farge D, Badoglio M, Lindsay JO, Muraro PA, Snowden JA, Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT)

doi: 10.1016/j.jaut.2018.06.002.

Selective T-cell depletion targeting CD45RA reduces viremia and enhances early T-cell recovery compared to CD3-targeted T-cell depletion

Transpl Infect Dis.

Triplett BM, Muller B, Kang G, Ying L, Cross SJ, Moen J, Cunningham L, Janssen W, Mamcarz E, Shook DR, Srinivasan A, Choi J, Hayden RT, Leung W

doi: 10.1111/tid.12823.

T Cells

Immune modulation via T regulatory cell enhancement: disease-modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases - An EAACI position paper of the Task Force on Immunopharmacology (TIPCO)

Allergy.

Roth-Walter F, Adcock IM, Benito-Villalvilla C, Bianchini R, Bjermer L, Boyman O, Caramori G, Cari L, Chung KF, Diamant Z, Eguiluz-Gracia I, Knol EF, Kolios A, Levi-Schaffer F, Nocentini G, Palomares O, Redegeld F, Van Esch B, Stellato C

doi: 10.1111/all.14478.

Related content

Histological and clinical cross-sectional study of chronic hair loss in patients with cutaneous chronic graft-versus-host disease

Dipeptidyl Peptidase 4 Inhibition for Prophylaxis of Acute Graft-versus-Host Disease

Dipeptidyl Peptidase 4 Inhibition for Prophylaxis of Acute Graft-versus-Host Disease

MicroRNA-155 Modulates Acute Graft-versus-Host Disease by Impacting T Cell Expansion, Migration, and Effector Function

Inflammatory Bowel Disease in Chronic Granulomatous Disease: an emerging problem over a twenty years' experience

Outcome of Non-hematological Autoimmunity After Hematopoietic Cell Transplantation in Children with Primary Immunodeficiency

Hematopoietic stem cell therapy for autoimmune diseases - Clinical experience and mechanisms

Selective T-cell depletion targeting CD45RA reduces viremia and enhances early T-cell recovery compared to CD3-targeted T-cell depletion

Immune modulation via T regulatory cell enhancement: disease-modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases - An EAACI position paper of the Task Force on Immunopharmacology (TIPCO)